10 June 2025 : Original article
Surgical Complications After Kidney Transplantation
Tímea Blichová ABCDEF 1,2, Patrícia Kleinová C 1,2*, Matej Vnučák CE 1,2, Karol Graňák CE 1,2, Andrej Kollár C 1,2, Jan Svihra Jr. C 3, Juraj Miklušica C 4, Ivana Dedinská ACE 1,2DOI: 10.12659/AOT.948531
Ann Transplant 2025; 30:e948531
Table 3 Characteristics of the cohort in relation to surgical complications.
| Number of patients: n=43Number of complications: n=45 | Surgical complicationsn=45 |
|---|---|
| Men (%) | 46.5 (n=20) |
| Age in time of KT (years) ±SD | 52.8±13.9 |
| Surgical complication follow-up (months) ±SD | 5.4±8.6. median 2 |
| SCD (%) | 60.5 (n=26) |
| ECD (%) | 32.5 (n=14) |
| LD (%) | 7 (n=3) |
| Kidney sent from another center (%) | 44.2 (n=19) |
| Basiliximab induction (%) | 74.4 (n=32) |
| Antithymocyte globulin induction (%) | 18.6 (n=8) |
| No induction (%) | 6.7 (n=3) |
| Diabetes mellitus (%) | 46.5 (n=20) |
| BMI (kg/m) | 25.6±4.3 |
| BK positivity (%) | 25.6 (n=11) |
| Average BK viremia (copies/ml) ±SD | 8000±16500 |
| BK viremia follow-up (months) ±SD | 8.7±15.2 |
| Antiplatelet therapy (%) | 93 (n=40) |
| Dual antiplatelet therapy (%) | 2.3 (n=1) |
| SD – standard deviation; KT – kidney transplantation; SCD – standard-criteria donor; ECD – extended-criteria donor; LD – living donor. | |